Cargando…

Machine Learning and Deep Learning for the Pharmacogenomics of Antidepressant Treatments

A growing body of evidence now proposes that machine learning and deep learning techniques can serve as a vital foundation for the pharmacogenomics of antidepressant treatments in patients with major depressive disorder (MDD). In this review, we focus on the latest developments for pharmacogenomics...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Eugene, Lin, Chieh-Hsin, Lane, Hsien-Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean College of Neuropsychopharmacology 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553527/ https://www.ncbi.nlm.nih.gov/pubmed/34690113 http://dx.doi.org/10.9758/cpn.2021.19.4.577

Ejemplares similares

Precision Psychiatry Applications with Pharmacogenomics: Artificial Intelligence and Machine Learning Approaches
por: Lin, Eugene, et al.
Publicado: (2020)

Deep Learning with Neuroimaging and Genomics in Alzheimer’s Disease
por: Lin, Eugene, et al.
Publicado: (2021)

Machine Learning and Novel Biomarkers for the Diagnosis of Alzheimer’s Disease
por: Chang, Chun-Hung, et al.
Publicado: (2021)

Applying a bagging ensemble machine learning approach to predict functional outcome of schizophrenia with clinical symptoms and cognitive functions
por: Lin, Eugene, et al.
Publicado: (2021)

Prediction of functional outcomes of schizophrenia with genetic biomarkers using a bagging ensemble machine learning method with feature selection
por: Lin, Eugene, et al.
Publicado: (2021)

Machine learning and systems genomics approaches for multi-omics data
por: Lin, Eugene, et al.
Publicado: (2017)

Pharmacogenomics‐Driven Prediction of Antidepressant Treatment Outcomes: A Machine‐Learning Approach With Multi‐trial Replication
por: Athreya, Arjun P., et al.
Publicado: (2019)

Combination of G72 Genetic Variation and G72 Protein Level to Detect Schizophrenia: Machine Learning Approaches
por: Lin, Eugene, et al.
Publicado: (2018)

Pharmacogenomics of antidepressant treatment effects
por: Licinio, Julio, et al.
Publicado: (2011)

Pharmacogenomics in depression and antidepressants
por: Bondy, Brigitta
Publicado: (2005)

Pharmacogenomic strategy for individualizing antidepressant therapy
por: Lin, Keh-Ming, et al.
Publicado: (2008)

Prediction of Antidepressant Treatment Response and Remission Using an Ensemble Machine Learning Framework
por: Lin, Eugene, et al.
Publicado: (2020)

Pharmacogenomics: A focus on antidepressants and atypical antipsychotics
por: Lister, Jonathan F.
Publicado: (2016)

Editorial: The Potential of Machine Learning in Pharmacogenetics, Pharmacogenomics and Pharmacoepidemiology
por: Garcia-Agundez, Augusto, et al.
Publicado: (2022)

Relevant Applications of Generative Adversarial Networks in Drug Design and Discovery: Molecular De Novo Design, Dimensionality Reduction, and De Novo Peptide and Protein Design
por: Lin, Eugene, et al.
Publicado: (2020)

Combining machine learning algorithms for prediction of antidepressant treatment response
por: Kautzky, Alexander, et al.
Publicado: (2020)

Cystine/Glutamate Antiporter in Schizophrenia: From Molecular Mechanism to Novel Biomarker and Treatment
por: Hung, Chung-Chieh, et al.
Publicado: (2021)

Editorial: The Potential of Machine-learning in Pharmacogenetics, Pharmacogenomics and Pharmacoepidemiology: Volume II
por: Garcia-Agundez, Augusto, et al.
Publicado: (2023)

Pharmacovariome scanning using whole pharmacogene resequencing coupled with deep computational analysis and machine learning for clinical pharmacogenomics
por: Tafazoli, Alireza, et al.
Publicado: (2023)

Pharmacogenomic testing and antidepressant response: problems and promises
por: Smith, Tawny L., et al.
Publicado: (2020)

Machine Learning-Based Definition of Symptom Clusters and Selection of Antidepressants for Depressive Syndrome
por: Kim, Il Bin, et al.
Publicado: (2021)

Genetic Biomarkers on Age-Related Cognitive Decline
por: Lin, Chieh-Hsin, et al.
Publicado: (2017)

Machine Learning and Deep Learning Applications in Multiple Myeloma Diagnosis, Prognosis, and Treatment Selection
por: Allegra, Alessandro, et al.
Publicado: (2022)

Genetic Effects of DISC1 and G72 (DAOA) on Visual Learning of Patients with Schizophrenia
por: Chang, Jane Pei-Chen, et al.
Publicado: (2020)

New Treatment Strategies of Depression: Based on Mechanisms Related to Neuroplasticity
por: Huang, Yu-Jhen, et al.
Publicado: (2017)

Machine learning and deep learning applications in microbiome research
por: Hernández Medina, Ricardo, et al.
Publicado: (2022)

A Deep Learning Approach for Predicting Antidepressant Response in Major Depression Using Clinical and Genetic Biomarkers
por: Lin, Eugene, et al.
Publicado: (2018)

A novel machine learning-based approach for the computational functional assessment of pharmacogenomic variants
por: Pandi, Maria-Theodora, et al.
Publicado: (2021)

Predicting the Treatment Outcomes of Antidepressants Using a Deep Neural Network of Deep Learning in Drug-Naïve Major Depressive Patients
por: Tsai, Ping-Lin, et al.
Publicado: (2022)

An Ensemble Approach to Predict Schizophrenia Using Protein Data in the N-methyl-D-Aspartate Receptor (NMDAR) and Tryptophan Catabolic Pathways
por: Lin, Eugene, et al.
Publicado: (2020)

Introduction to Machine Learning and Deep Learning
por: Kagan, Michael
Publicado: (2023)

Artificial intelligence, machine learning, and deep learning in orthopedic surgery
por: Atik, O. Şahap
Publicado: (2022)

Artificial Intelligence, Machine Learning and Deep Learning in Ion Channel Bioinformatics
por: Ashrafuzzaman, Md.
Publicado: (2021)

Machine Learning and Deep Learning in Cardiothoracic Imaging: A Scoping Review
por: Khosravi, Bardia, et al.
Publicado: (2022)

Pharmacists as facilitators of pharmacogenomic guidance for antidepressant drug selection and dosing
por: Bishop, Jeffrey R.
Publicado: (2021)

Pharmacogenomic biomarkers as source of evidence of the effectiveness and safety of antidepressant therapy
por: Correia, Catarina, et al.
Publicado: (2022)

How machine-learning recommendations influence clinician treatment selections: the example of antidepressant selection
por: Jacobs, Maia, et al.
Publicado: (2021)

Deep learning and machine learning in psychiatry: a survey of current progress in depression detection, diagnosis and treatment
por: Squires, Matthew, et al.
Publicado: (2023)

The application of traditional machine learning and deep learning techniques in mammography: a review
por: Gao, Ying’e, et al.
Publicado: (2023)

Pharmacogenomics of Hypertension Treatment
por: Rysz, Jacek, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8901l6q9g6n2vb3or1h1qp8jhk